nanollose Limited (ASX:NC6)

ALERT: Price-sensitive ASX Announcement for NC6

Current share price for NC6 : $0.076 0.006 (8.57%)⁺

Announcement

Quarterly Activities/Appendix 4C Cash Flow Report

Release

31 Jul 2026 8:36AM

Price at Release

$0.070

Full Release

Summary

Nanollose Limited's quarterly report for the period ending 30 June 2026 highlights its strategic initiatives including the onshoring of analytic and testing capabilities to Australia, enhancing the speed and control of product development. The company is advancing its microbial cellulose production with successful local trials and plans for a pilot-scale facility. Financially, Nanollose raised $1.58 million through options, ending the quarter with a cash balance of $1.35 million. The report outlines net operating cash outflows of $647,000, involving R&D, marketing, staff, and administrative costs, and emphasizes ongoing efforts to refine and validate its production processes to meet market demands.

Key Points

Nanollose is onshoring its core production, analytics, and testing capabilities to Western Australia.
Received $1.58 million in funding through option conversion.
Ended the quarter with a cash balance of $1.35 million.
Net operating cash outflows of $647,000 in the quarter.
Strategic emphasis on establishing a microbial cellulose pilot facility.
Successful local trials for industrial dewatering and washing processes.
Demand from a high-profile brand for specialized fibre samples.
Appendix 4C report outlines detailed cash flows and financial activities.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.